BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12770838)

  • 1. Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.
    Okusa MD; Ye H; Huang L; Sigismund L; Macdonald T; Lynch KR
    Am J Physiol Renal Physiol; 2003 Sep; 285(3):F565-74. PubMed ID: 12770838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
    Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
    Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.
    Awad AS; Ye H; Huang L; Li L; Foss FW; Macdonald TL; Lynch KR; Okusa MD
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1516-24. PubMed ID: 16403835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.
    Xu Y; Jiang G; Tsukahara R; Fujiwara Y; Tigyi G; Prestwich GD
    J Med Chem; 2006 Aug; 49(17):5309-15. PubMed ID: 16913720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
    Day YJ; Marshall MA; Huang L; McDuffie MJ; Okusa MD; Linden J
    Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G285-93. PubMed ID: 14715520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.
    Hasegawa Y; Erickson JR; Goddard GJ; Yu S; Liu S; Cheng KW; Eder A; Bandoh K; Aoki J; Jarosz R; Schrier AD; Lynch KR; Mills GB; Fang X
    J Biol Chem; 2003 Apr; 278(14):11962-9. PubMed ID: 12554733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway.
    Murph MM; Scaccia LA; Volpicelli LA; Radhakrishna H
    J Cell Sci; 2003 May; 116(Pt 10):1969-80. PubMed ID: 12668728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury.
    Zahedi K; Wang Z; Barone S; Prada AE; Kelly CN; Casero RA; Yokota N; Porter CW; Rabb H; Soleimani M
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1046-55. PubMed ID: 12554636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist.
    Heise CE; Santos WL; Schreihofer AM; Heasley BH; Mukhin YV; Macdonald TL; Lynch KR
    Mol Pharmacol; 2001 Dec; 60(6):1173-80. PubMed ID: 11723223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
    Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
    J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys.
    Yang CC; Chien CT; Wu MH; Ma MC; Chen CF
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1433-40. PubMed ID: 18272600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Netrin-1 regulates Th1/Th2/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia-reperfusion injury.
    Tadagavadi RK; Wang W; Ramesh G
    J Immunol; 2010 Sep; 185(6):3750-8. PubMed ID: 20693423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid receptors 2 and 3 regulate erythropoiesis at different hematopoietic stages.
    Chiang JC; Chen WM; Lin KH; Hsia K; Ho YH; Lin YC; Shen TL; Lu JH; Chen SK; Yao CL; Chen BPC; Lee H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158818. PubMed ID: 33035680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of analogues of lysophosphatidic acid (LPA): oleoyl-sn-glycero-3-phosphate (L-alpha-LPA) and 1-oleoyl-2-O-methyl-rac-glycerophosphothionate (OMPT) in uterine smooth muscle contractility of the pregnant pigs.
    Markiewicz W; Kamińska K; Bogacki M; Maślanka T; Jaroszewski J
    Pol J Vet Sci; 2012; 15(4):635-43. PubMed ID: 23390752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
    Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
    J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of guanylyl cyclase-G protects against acute renal injury.
    Lin H; Cheng CF; Hou HH; Lian WS; Chao YC; Ciou YY; Djoko B; Tsai MT; Cheng CJ; Yang RB
    J Am Soc Nephrol; 2008 Feb; 19(2):339-48. PubMed ID: 18199799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation.
    Subramanian P; Karshovska E; Reinhard P; Megens RT; Zhou Z; Akhtar S; Schumann U; Li X; van Zandvoort M; Ludin C; Weber C; Schober A
    Circ Res; 2010 Jul; 107(1):96-105. PubMed ID: 20360252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury.
    Jung YJ; Kim DH; Lee AS; Lee S; Kang KP; Lee SY; Jang KY; Sung MJ; Park SK; Kim W
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F952-60. PubMed ID: 19656917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.
    Day YJ; Huang L; Ye H; Linden J; Okusa MD
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F722-31. PubMed ID: 15561971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.